Science
Swiss Study to Prospectively Assess Value of Multi-Omic, Functional Tumor Profiling – Precision Oncology News
The TuPro study will evaluate whether a comprehensive suite of routine and emerging tests can add value to treatment decision making and improve outcomes.
This article has been updated with the number of patients involved in the study and timeline details.
NEW YORK A group of researchers in Switzerland has set out to show the feasibility of incorporating a comprehensive suite of tumor profiling technologies into the treatment decision-making process for cancer patients and prove that such a multi-omics approach will add value over standard approaches and improve precision therapy decisions.
The researchers outlined the design and aims of the Tumor…
-
Noosa News19 hours agoThe Pedro Pascal-Led Fantastic Four Face Julia Garner’s Silver Surfer in the New Full ‘First Steps’ Trailer
-
General18 hours agoFrom Humpty Doo to the bush, these voters’ views reflect the challenge for federal politicians
-
Noosa News23 hours agoMeet Llew O’Brien, LNP | Noosa Today
-
Noosa News21 hours agoQueensland set for ‘comfortable’ weather over Easter long weekend